Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,201-16,212 of 23,847
Other study type icon
Active Not RecruitingNCT03221127

Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component)

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Location not clearly listed
DepressionOtherFrom 42 Years to 73 Years
Countries
Sponsor
University of Eastern Finland
Condition
Depression
Drug study icon
CompletedNCT01706965

Kuvan in People With Schizophrenia and Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In New York
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT00718510

L-arginine in Treatment as Usual in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Edmonton
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Alberta
Condition
Schizophrenia
Drug study icon
WithdrawnNCT04054973

L-arginine Study for Persistent Symptoms of Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

In Worcester
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Schizophrenia
Drug study icon
CompletedNCT00177463

L-Carnosine for Bipolarity type I

This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Bridgeville
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Bipolarity
Drug study icon
CompletedNCT00177177

L-carnosine for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bridgeville
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Schizophrenia
Drug study icon
CompletedNCT01853280

L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In Boston
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Other study type icon
CompletedNCT00372151

L-Theanine in the Management of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Beersheba
SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Israel
Sponsor
Sha'ar Menashe Mental Health Center
Condition
Schizophrenia
Drug study icon
CompletedNCT02558790

L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD

This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In Boston
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Drug study icon
CompletedNCT00799409

Lab School Day Study for CONCERTA of Older Children With ADHD

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Irvine
ADHDDrugFrom 9 Years to 12 Years
Countries
United States
Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Condition
ADHD
Device study icon
CompletedNCT02520349

Lab to Real World Assessment of E-cigarette Abuse Liability and Appeal

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Washington D.C.
AddictionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Truth Initiative
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.